Public-registry site landscape for NCT04678206, a Refractory Chronic Cough study sponsored by Bellus Health Inc. - a GSK company. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04678206 (registry record) |
| Sponsor | Bellus Health Inc. - a GSK company |
| Condition(s) | Refractory Chronic Cough |
| Phase | PHASE2 |
| Listed sites | 116 |
| Site countries | United States, Canada, Czechia, Germany, Hungary, Poland, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT04678206 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →